- Home
- LSBK vs IPA Comparison
LSBK vs IPA Comparison
Compare LSBK & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- IPA
- Stock Information
- Founded
- LSBK 1891
- IPA 1983
- Country
- LSBK United States
- IPA United States
- Employees
- LSBK N/A
- IPA N/A
- Industry
- LSBK Savings Institutions
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- LSBK Finance
- IPA Health Care
- Exchange
- LSBK Nasdaq
- IPA Nasdaq
- Market Cap
- LSBK 90.0M
- IPA 74.6M
- IPO Year
- LSBK 2006
- IPA 2017
- Fundamental
- Price
- LSBK $12.15
- IPA $2.16
- Analyst Decision
- LSBK
- IPA Strong Buy
- Analyst Count
- LSBK 0
- IPA 2
- Target Price
- LSBK N/A
- IPA $4.00
- AVG Volume (30 Days)
- LSBK 220.7K
- IPA 2.1M
- Earning Date
- LSBK 07-23-2025
- IPA 09-15-2025
- Dividend Yield
- LSBK 4.44%
- IPA N/A
- EPS Growth
- LSBK 40.80
- IPA N/A
- EPS
- LSBK 1.06
- IPA N/A
- Revenue
- LSBK $26,488,000.00
- IPA $16,581,105.00
- Revenue This Year
- LSBK N/A
- IPA $4.67
- Revenue Next Year
- LSBK N/A
- IPA $14.15
- P/E Ratio
- LSBK $11.51
- IPA N/A
- Revenue Growth
- LSBK 1.75
- IPA 1.34
- 52 Week Low
- LSBK $11.50
- IPA $0.27
- 52 Week High
- LSBK $12.50
- IPA $2.41
- Technical
- Relative Strength Index (RSI)
- LSBK 62.69
- IPA 66.79
- Support Level
- LSBK $11.50
- IPA $1.61
- Resistance Level
- LSBK $12.38
- IPA $1.85
- Average True Range (ATR)
- LSBK 0.25
- IPA 0.30
- MACD
- LSBK 0.03
- IPA 0.02
- Stochastic Oscillator
- LSBK 72.21
- IPA 73.68
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.